Characterisation and physical stability of PEGylated glucagon

International Journal of Pharmaceutics

Volumn 330, Issue 1-2, 2007, Pages 89-98

  Stigsnaes, Pernille ^a   Frokjaer, Sven ^a   Bjerregaard, Simon ^b   van de Weert, Marco ^a   Kingshott, Peter ^c   Moeller, E Horn ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Fibrillation; Freeze drying; Glucagon; PEGylation; Physical stability; Secondary structure

Indexed keywords

GLUCAGON; LYSINE; MACROGOL DERIVATIVE; THIOFLAVINE;

ALPHA HELIX; ARTICLE; BETA SHEET; CIRCULAR DICHROISM; COMPARATIVE STUDY; DRUG CONFORMATION; DRUG PURIFICATION; DRUG STABILITY; FIBER; FREEZE DRYING; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STEREOSPECIFICITY;

CIRCULAR DICHROISM; DRUG STABILITY; GLUCAGON; POLYETHYLENE GLYCOLS; PROTEIN STRUCTURE, SECONDARY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THIAZOLES;

EID: 33846186433     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.09.002     Document Type: Article

References (46)

1. Bailon P., and Berthold W. Polyethylene glycol-conjugated pharmaceutical proteins. Pharm. Sci. Technol. Today 1 (1998) 352-356
2. Barth A., and Zscherp C. What vibrations tell us about proteins. Quart. Rev. Biophys. 35 (2002) 369-430
3. Beaven G.H., Gratzer W.B., and Davies H.G. Formation and structure of gels and fibrils from glucagon. Eur. J. Biochem. 11 (1969) 37-42
4. Bhadra D., Bhadra S., Jain P., and Jain N.K. Pegnology: a review of PEGylated systems. Pharmazie 57 (2002) 5-29
5. Blundell T.L. The conformation of glucagon. In: Lefébvre P.J. (Ed). Glucagon vol. 1 (1983), Springer-Verlag, Germany 37-56
6. Chou P.Y., and Fasman G.D. The conformation of glucagon: predictions and consequences. Biochemistry 14 (1975) 2536-2541
7. Clark R., Olson K., Fuh G., Marian M., Mortensen D., Teshima G., Chang S., Chu H., Mukku V., Canova-Davis E., Somers T., Cronin M., Winkler M., and Wells J.A. Long-acting growth hormones produced by conjugation with polyethylene glycol. J. Biol. Chem. 271 (1996) 21969-21977
8. Dong A., Huang P., and Caughey W.S. Protein secondary structures in water from second-derivative amide I infrared spectra. Biochemistry 29 (1990) 3303-3308
9. Frokjaer S., and Otzen D.E. Protein drug stability: a formulation challenge. Nat. Rev. Drug Discov. 4 (2005) 298-306
10. Glasoe P.K., and Long F.A. Use of glass electrodes to measure acidities in deuterium oxide. J. Phys. Chem. 64 (1960) 188-189
11. Gratzer W.B., and Beaven G.H. Relation between conformation and association state. A study of the association equilibrium of glucagon. J. Biol. Chem. 244 (1969) 6675-6679
12. Gratzer W.B., Creeth J.M., and Beaven G.H. Presence of trimers in glucagon solution. Eur. J. Biochem. 31 (1972) 505-509
13. Grillo A.O., Edwards K.L., Kashi R.S., Shipley K.M., Hu L., Besman M.J., and Middaugh C.R. Conformational origin of the aggregation of recombinant human factor VIII. Biochemistry 40 (2001) 586-595
14. Haris P.I., and Chapman D. The conformational analysis of peptides using Fourier transform IR spectroscopy. Biopolymers 37 (1995) 251-263
15. Harper J.D., and Lansbury Jr. P.T. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66 (1997) 385-407
16. Harris J.M., and Chess R.B. Effect of PEGylation on pharmaceuticals. Nat. Rev. Drug Discov. 2 (2003) 214-221
17. Hearn M.T., and Zhao G. Investigations into the thermodynamics of polypeptide interaction with non-polar ligands. Anal. Chem. 71 (1999) 4874-4885
18. Hinds K.D., and Kim S.W. Effects of PEG conjugation on insulin properties. Adv. Drug Deliv. Rev. 54 (2002) 505-530
19. Jackson M., and Mantsch H.H. The use and misuse of FTIR spectroscopy in the determination of protein structure. Crit. Rev. Biochem. Mol. Biol. 30 (1995) 95-120
20. Johnsson A.P. Mass spectrometry for protein and peptide characterisation. Cell. Mol. Life Sci. 58 (2001) 868-884
21. Kendrick B.S., Dong A., Allison S.D., Manning M.C., and Carpenter J.F. Quantitation of the area of overlap between second-derivative amide I infrared spectra to determine the structural similarity of a protein in different states. J. Pharm. Sci. 85 (1996) 155-158
22. Kennedy D.F., Crisma M., Toniolo C., and Chapman D. Studies of peptides forming 3(10)- and alpha-helices and beta-bend ribbon structures in organic solution and in model biomembranes by Fourier transform infrared spectroscopy. Biochemistry 30 (1991) 6541-6548
23. Kim T.H., Lee H., and Park T.G. PEGylated recombinant human epidermal growth factor (rhEGF) for sustained release from biodegradable PLGA microspheres. Biomaterials 23 (2002) 2311-2317
24. Kinstler O.B., Brems D.N., Lauren S.L., Paige A.G., Hamburger J.B., and Treuheit M.J. Characterisation and stability of N-terminally PEGylated rhG-CSF. Pharm. Res. 15 (1996) 996-1002
25. Lee H., and Park T.G. Preparation and characterization of mono-PEGylated epidermal growth factor: evaluation of in vitro biologic activity. Pharm. Res. 19 (2002) 845-851
26. LeVine H. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2 (1993) 404-410
27. Morpurgo M., and Veronese F.M. Conjugates of peptides and proteins to polyethylene glycol. Methods Mol. Biol. 283 (2004) 45-70
28. Na D.H., Park M.O., Choi S.Y., Kim Y.S., Lee S.S., Yoo S.D., Lee H.S., and Lee K.C. Identification of the modifying sites of mono-PEGylated salmon calcitonins by capillary electrophoresis and MALDI-TOF mass spectrometry. J. Chromatogr. B 754 (2001) 259-263
29. Nielsen L., Khurana R., Coats A., Frokjaer S., Brange J., Vyas S., Uversky V.N., and Fink A.L. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 40 (2001) 6036-6046
30. Nilsson M.R. Techniques to study amyloid fibril formation in vitro. Methods 34 (2004) 151-160
31. Nilsson M.R., and Raleigh D.P. Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin. J. Mol. Biol. 294 (1999) 1375-1385
32. Nucci M.L., Shorr R., and Abuchowski A. The therapeutic value of poly(ethylene glycol)-modified proteins. Adv. Drug Deliv. Rev. 6 (1991) 133-151
33. Ohnishi S., and Takano K. Amyloid fibrils from the viewpoint of protein folding. Cell. Mol. Life Sci. 61 (2004) 511-524
34. Onoue S., Ohshima K., Debari K., Koh K., Shioda S., Iwasa S., Kashimoto K., and Yajima T. Mishandling of the therapeutic peptide glucagon generates cytotoxic amyloidogenic fibrils. Pharm. Res. 21 (2004) 1274-1283
35. Overcashier D.E., Brooks D.A., Costantino H.R., and Hsu C.C. Preparation of excipient-free recombinant human tissue-type plasminogen activator by lyophilization from ammonium bicarbonate solution: an investigation of the two-stage sublimation phenomenon. J. Pharm. Sci. 86 (1997) 455-459
36. Pace C.N., Vajdos F., Fee L., Grimsley G., and Gray T. How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 4 (1995) 2411-2423
37. Panijpan B., and Gratzer W.B. Conformational nature of monomeric glucagon. Eur. J. Biochem. 45 (1974) 547-553
38. Toniolo C., Formaggio F., Tognon S., Broxterman Q.B., Kaptein B., Huang R., Setnicka V., Keiderling T.A., McColl I.H., Hecht L., and Barron L.D. The complete chirospectroscopic signature of the peptide 3(10)-helix in aqueous solution. Biopolymers 75 (2004) 32-45
39. Tran C.D., Beddard G.S., and Osborne A.D. Secondary structure and dynamics of glucagon in solution. Biochim. Biophys. Acta 709 (1982) 256-264
40. Veronese F.M. Peptide and protein PEGylation: a review of problems and solutions. Biomaterials 22 (2001) 405-417
41. Veronese F.M., and Harris J.M. Introduction and overview of peptide and protein PEGylation. Adv. Drug Deliv. Rev. 54 (2002) 453-456
42. Veronese F.M., and Morpurgo M. Bioconjugation in pharmaceutical chemistry. Farmaco 54 (1999) 497-516
43. Voropai E.S., Samtsov M.P., Kaplevskii K.N., Maskevich A.A., Stepuro V.I., Porarova O.I., Kuznetsova I.M., Turoverov K.K., Fink A.L., and Uverskii V.N. Spectral properties of Thioflavin T and its complexes with amyloid fibrils. J. Appl. Spectrosc. 70 (2003) 868-874
44. Wang W. Lyophilization and development of solid protein pharmaceuticals. Int. J. Pharm. 203 (2000) 1-60
45. Wu C.S., Hachimori A., and Yang J.T. Lipid-induced ordered conformation of some peptide hormones and bioactive oligopeptides: predominance of helix over beta form. Biochemistry 21 (1982) 4556-4562
46. Wu C.S., and Yang J.T. Helical conformation of glucagon in surfactant solutions. Biochemistry 19 (1980) 2117-2122